期刊： CLINICAL GENITOURINARY CANCER, 2021; 19 (4)
The location of lesions on multiparametric magnetic resonance imaging has never been separately considered previously when making biopsy decisions for......
期刊： CLINICAL GENITOURINARY CANCER, 2021; 19 (2)
This study analyzed the Surveillance, Epidemiology, and End Results (SEER) database concerning the characteristics of primary renal neuroendocrine neo......
期刊： CLINICAL GENITOURINARY CANCER, 2021; 19 (3)
We assessed the prognostic value of preoperative monocyte-to-lymphocyte ratio to predict intravesical recurrence in upper urinary tract urothelial car......
期刊： CLINICAL GENITOURINARY CANCER, 2021; 19 (4)
Oligometastatic prostate cancer (OMPC) is an intermediate state observed along the spectrum of the natural history of prostate cancer. This study inve......
期刊： CLINICAL GENITOURINARY CANCER, 2021; 19 (4)
There exist several viable first-line treatment options for metastatic renal cell carcinoma, making the choice of initial therapy difficult. Metrics o......
期刊： CLINICAL GENITOURINARY CANCER, 2021; 19 (3)
Central nervous system (CNS) metastasis from prostate cancer (PCA) is a rare event, but one with significant prognostic impact. We retrospectively ide......
期刊： CLINICAL GENITOURINARY CANCER, 2020; 18 (1)
We retrospectively investigated the plasma fibrinogen and D-dimer as prognostic biomarkers in 206 patients undergoing transurethral resection of bladd......
期刊： CLINICAL GENITOURINARY CANCER, 2020; 18 (2)
We assessed the difference in the detection rate of prostate cancer, specifically clinically significant prostate cancer, using targeted biopsy (TB), ......
期刊： CLINICAL GENITOURINARY CANCER, 2020; 18 (3)
In this rare case, we report a young patient with advanced urachal carcinoma with abdominal wall infiltration. For this patient, we performed adjuvant......
期刊： CLINICAL GENITOURINARY CANCER, 2020; 18 (6)
Among patients with metastatic prostate cancer, local treatment might provide better survival benefits in decreasing cancer-specific mortality and all......
期刊： CLINICAL GENITOURINARY CANCER, 2020; 18 (5)
The present study focused on the detection of clinically significant prostate cancer in biopsy-naive patients with Prostate Imaging Reporting and Data......
期刊： CLINICAL GENITOURINARY CANCER, 2020; 18 (5)
This systematic review supports the use of non-steroidal anti-androgens in high-risk non-metastatic castrate-resistant prostate cancer. Indirect compa......
期刊： CLINICAL GENITOURINARY CANCER, 2020; 18 (1)
In the first-line (1L) setting, pazopanib (PAZ) has been recommended by the National Comprehensive Cancer Network for the treatment of advanced renal ......
期刊： CLINICAL GENITOURINARY CANCER, 2019; 17 (1)
We conducted a territory-wide, multicenter, age- and prostate-specific antigen-matched cohort study comparing chemohormonal therapy and hormonal thera......
